Medical Faculty, University of Bern, Switzerland.
Clinic of Angiology, University Hospital Zurich, Switzerland.
Thromb Res. 2022 Dec;220:65-71. doi: 10.1016/j.thromres.2022.10.006. Epub 2022 Oct 13.
Although the two manifestations of venous thromboembolism (VTE), deep vein thrombosis (DVT) and pulmonary embolism (PE), vary considerably, the consensus guidelines recommend similar algorithms for therapeutic anticoagulation in both conditions. Real-world data assessing contemporary management strategies in PE and DVT alone may help tailoring future recommendations towards more individualized patient care.
In the present analysis, we compared demographics, comorbidities, treatment patterns, and clinical outcomes of PE versus DVT only among 2062 consecutive patients with confirmed VTE enrolled by 11 acute care hospitals between November 2012 and February 2015 in the SWIss Venous ThromboEmbolism Registry (SWIVTER).
Overall, 1246 (60 %) patients were diagnosed with PE. In comparison to DVT alone, PE patients were older (66 vs. 59 years; p < 0.001), more frequently had acute and chronic comorbidities, less frequently had prior VTE and hormone replacement, and were less often pregnant. VTE was considered similarly often provoked in patients with PE and DVT alone (33.8 % vs. 33.5 %; p = 0.88). Anticoagulation for an indefinite duration was more often prescribed to patients with PE than those with DVT alone (45.7 vs. 19.6 %; p < 0.001), and PE diagnosis was the strongest independent predictor of indefinite anticoagulation (OR 3.21; 95 % CI 2.55-4.06; p < 0.001). Diagnosis of PE was associated with both increased risk of 90-day mortality (HR 2.31, 95 % CI 1.44-3.71; p = 0.001) and major bleeding (HR 3.88, 95 % CI 1.63-9.22; p = 0.002).
Our analysis affirms differences in demographics, risk factors, and clinical outcomes of PE versus DVT alone. In routine clinical practice, duration of anticoagulation is being managed differently between the two manifestations of VTE, in contrast to recommendations of the current consensus guidelines.
尽管静脉血栓栓塞症(VTE)的两种表现形式,深静脉血栓形成(DVT)和肺栓塞(PE),有很大的不同,但共识指南建议在这两种情况下使用相似的治疗抗凝算法。评估 PE 和 DVT 中当代管理策略的真实世界数据可能有助于针对更个体化的患者护理制定未来的建议。
在本分析中,我们比较了 2062 例连续确诊的 VTE 患者的人口统计学、合并症、治疗模式和临床结局,这些患者于 2012 年 11 月至 2015 年 2 月期间在瑞士静脉血栓栓塞症登记处(SWIVTER)由 11 家急性护理医院纳入。
总体而言,1246 例(60%)患者被诊断为 PE。与单独的 DVT 相比,PE 患者年龄更大(66 岁 vs. 59 岁;p<0.001),更常伴有急性和慢性合并症,较少有既往 VTE 和激素替代治疗,且较少怀孕。PE 和单独的 DVT 患者中同样认为 VTE 是相似程度的诱因(33.8% vs. 33.5%;p=0.88)。无期限抗凝治疗更常被开给 PE 患者,而不是单独的 DVT 患者(45.7% vs. 19.6%;p<0.001),PE 诊断是无期限抗凝治疗的最强独立预测因素(OR 3.21;95%CI 2.55-4.06;p<0.001)。PE 诊断与 90 天死亡率增加相关(HR 2.31,95%CI 1.44-3.71;p=0.001)和大出血(HR 3.88,95%CI 1.63-9.22;p=0.002)。
我们的分析证实了 PE 与单独的 DVT 在人口统计学、危险因素和临床结局方面的差异。在常规临床实践中,与当前共识指南的建议相反,两种 VTE 表现形式的抗凝持续时间管理不同。